aluates Reports

$ 0.0

Automative

Global Pet Pharmaceuticals Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Published Date: August 2025

Report Code: QYRE-Auto-17O9144

Global Pet Pharmaceuticals Market Outlook 2022

BUY CHAPTERS

Global Pet Pharmaceuticals Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Code: QYRE-Auto-17O9144

Report

August 2025

Pages:107

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Zoetis Inc

Boehringer Ingelheim

Elanco

Virbac

Dechra Veterinary Products

Ceva

Vetoquinol

Ouro Fino Saude

Norbrook

Jindun

Chopperlvya Animal Health

CAHIC

Merck

Animalcare Group

Parnell

ringpu

Jinyu Group

Kyoritsu Seiyaku

Pet Pharmaceuticals Sales Market Size

The global Pet Pharmaceuticals market size was US$ 17510 million in 2024 and is forecast to a readjusted size of US$ 28170 million by 2031 with a CAGR of 7.0% during the forecast period 2025-2031.

Pet Pharmaceuticals Sales Market

Pet pharmaceutical refers specifically to medicines given to pets. In terms of the purpose of use, pet drugs are mainly used by dogs and cats. Through drug prevention and treatment of pet diseases, the cure rate of pet diseases can be improved, the physical and mental health of pets can be guaranteed, and the quality of life of pets can be improved. In terms of clinical significance, the application of pet drugs can provide clinical data for the research and development of new pet drugs, and promote the replacement and upgrading of new pet drugs.

The pet pharmaceuticals market is experiencing strong growth, driven by the rising trend of pet humanization, increasing pet ownership, and heightened awareness of animal health. As more people consider pets as part of the family, spending on veterinary care and pharmaceuticals has surged globally. Advancements in veterinary medicine have also contributed to the development of more targeted and effective drugs for chronic diseases, pain management, parasitic infections, and preventive care. Additionally, the growing elderly population and single households have led to higher demand for companion animals, further fueling the market. Pet insurance is becoming more widespread, especially in North America and Europe, making veterinary drugs more accessible and affordable to pet owners. These factors collectively boost the demand for both prescription and over-the-counter pet medications.

Despite promising growth, the pet pharmaceuticals market faces several challenges. Regulatory requirements for veterinary drugs are becoming stricter, increasing the time and cost needed for product development and approval. Additionally, counterfeit and low-quality medications, particularly in developing regions, can undermine the trust of veterinarians and pet owners. Limited availability of skilled veterinary professionals in some countries also affects the diagnosis and prescription of appropriate pharmaceutical treatments. Another barrier is the high cost of innovative pet drugs, which can deter adoption, especially among lower-income pet owners. Moreover, competition from alternative therapies and natural remedies is rising, presenting additional challenges for pharmaceutical companies to differentiate their products in an increasingly crowded marketplace.

The major players in global Pet Pharmaceuticals market include Zoetis, Boehringer Ingelheim, Merck, etc. The top 3 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy about 80% of the global market. Antiparasitic is the main type, with a share about 30%. Prevention is the main application, which holds a share about 80%.

The global Pet Pharmaceuticals market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.

Market Segmentation

Scope of Pet Pharmaceuticals Sales Market Report

Report Metric	Details
Report Name	Pet Pharmaceuticals Sales Market
Forecasted market size in 2031	US$ 28170 million
CAGR	7.0%
Forecasted years	2025 - 2031
By Type: (Dominant Segment vs High-Margin Innovation)	Antiparasitic Biological Products Antibacterial Others
By Application: (Core Demand Driver vs Emerging Opportunity)	Prevention Treatment
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company:	Zoetis, Boehringer Ingelheim, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Ouro Fino Saude, Norbrook, Jindun, Chopperlvya Animal Health, CAHIC, Animalcare Group, Parnell, Ringpu, Jinyu Group, Kyoritsu Seiyaku
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Pet Pharmaceuticals market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Biological Products in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Treatment in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Pet Pharmaceuticals value chain, addressing:

FAQ for this report

What is the Pet Pharmaceuticals Sales Market size in 2031?

Ans: The Pet Pharmaceuticals Sales Market size in 2031 will be US$ 28170 million.

What is the market share of major companies in Pet Pharmaceuticals Sales Market?

Ans: The top 3 players occupy about 60% shares of the global market.

What is the Pet Pharmaceuticals Sales Market share by type?

Ans: Antiparasitic is the main type, with a share about 30%.

What is the Pet Pharmaceuticals Sales Market share by application?

Ans: Prevention is the main application, which holds a share about 80%.

Who are the main players in the Pet Pharmaceuticals Sales Market report?

Ans: The main players in the Pet Pharmaceuticals Sales Market are Zoetis, Boehringer Ingelheim, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Ouro Fino Saude, Norbrook, Jindun, Chopperlvya Animal Health, CAHIC, Animalcare Group, Parnell, Ringpu, Jinyu Group, Kyoritsu Seiyaku

What are the Application segmentation covered in the Pet Pharmaceuticals Sales Market report?

Ans: The Applications covered in the Pet Pharmaceuticals Sales Market report are Prevention, Treatment

What are the Type segmentation covered in the Pet Pharmaceuticals Sales Market report?

Ans: The Types covered in the Pet Pharmaceuticals Sales Market report are Antiparasitic, Biological Products, Antibacterial, Others

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031

1.2.2 Antiparasitic

1.2.3 Biological Products

1.2.4 Antibacterial

1.2.5 Others

1.3 Market by Application

1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031

1.3.2 Prevention

1.3.3 Treatment

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Pet Pharmaceuticals Market Perspective (2020-2031)

2.2 Global Market Size by Region: 2020 VS 2024 VS 2031

2.3 Global Pet Pharmaceuticals Revenue Market Share by Region (2020-2025)

2.4 Global Pet Pharmaceuticals Revenue Forecast by Region (2026-2031)

2.5 Major Region and Emerging Market Analysis

2.5.1 North America Pet Pharmaceuticals Market Size and Prospective (2020-2031)

2.5.2 Europe Pet Pharmaceuticals Market Size and Prospective (2020-2031)

2.5.3 China Pet Pharmaceuticals Market Size and Prospective (2020-2031)

2.5.4 Japan Pet Pharmaceuticals Market Size and Prospective (2020-2031)

3 Breakdown Data by Type

3.1 Global Pet Pharmaceuticals Historic Market Size by Type (2020-2025)

3.2 Global Pet Pharmaceuticals Forecasted Market Size by Type (2026-2031)

3.3 Different Types Pet Pharmaceuticals Representative Players

4 Breakdown Data by Application

4.1 Global Pet Pharmaceuticals Historic Market Size by Application (2020-2025)

4.2 Global Pet Pharmaceuticals Forecasted Market Size by Application (2026-2031)

4.3 New Sources of Growth in Pet Pharmaceuticals Application

5 Competition Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Pet Pharmaceuticals Players by Revenue (2020-2025)

5.1.2 Global Pet Pharmaceuticals Revenue Market Share by Players (2020-2025)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Pet Pharmaceuticals Revenue

5.4 Global Pet Pharmaceuticals Market Concentration Analysis

5.4.1 Global Pet Pharmaceuticals Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Pet Pharmaceuticals Revenue in 2024

5.5 Global Key Players of Pet Pharmaceuticals Head office and Area Served

5.6 Global Key Players of Pet Pharmaceuticals, Product and Application

5.7 Global Key Players of Pet Pharmaceuticals, Date of Enter into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments and Downstream

6.1.1 North America Pet Pharmaceuticals Revenue by Company (2020-2025)

6.1.2 North America Market Size by Type

6.1.2.1 North America Pet Pharmaceuticals Market Size by Type (2020-2025)

6.1.2.2 North America Pet Pharmaceuticals Market Share by Type (2020-2025)

6.1.3 North America Market Size by Application

6.1.3.1 North America Pet Pharmaceuticals Market Size by Application (2020-2025)

6.1.3.2 North America Pet Pharmaceuticals Market Share by Application (2020-2025)

6.1.4 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments and Downstream

6.2.1 Europe Pet Pharmaceuticals Revenue by Company (2020-2025)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe Pet Pharmaceuticals Market Size by Type (2020-2025)

6.2.2.2 Europe Pet Pharmaceuticals Market Share by Type (2020-2025)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe Pet Pharmaceuticals Market Size by Application (2020-2025)

6.2.3.2 Europe Pet Pharmaceuticals Market Share by Application (2020-2025)

6.2.4 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments and Downstream

6.3.1 China Pet Pharmaceuticals Revenue by Company (2020-2025)

6.3.2 China Market Size by Type

6.3.2.1 China Pet Pharmaceuticals Market Size by Type (2020-2025)

6.3.2.2 China Pet Pharmaceuticals Market Share by Type (2020-2025)

6.3.3 China Market Size by Application

6.3.3.1 China Pet Pharmaceuticals Market Size by Application (2020-2025)

6.3.3.2 China Pet Pharmaceuticals Market Share by Application (2020-2025)

6.3.4 China Market Trend and Opportunities

6.4 Japan Market: Players, Segments and Downstream

6.4.1 Japan Pet Pharmaceuticals Revenue by Company (2020-2025)

6.4.2 Japan Market Size by Type

6.4.2.1 Japan Pet Pharmaceuticals Market Size by Type (2020-2025)

6.4.2.2 Japan Pet Pharmaceuticals Market Share by Type (2020-2025)

6.4.3 Japan Market Size by Application

6.4.3.1 Japan Pet Pharmaceuticals Market Size by Application (2020-2025)

6.4.3.2 Japan Pet Pharmaceuticals Market Share by Application (2020-2025)

6.4.4 Japan Market Trend and Opportunities

7 Key Players Profiles

7.1 Zoetis

7.1.1 Zoetis Company Details

7.1.2 Zoetis Business Overview

7.1.3 Zoetis Pet Pharmaceuticals Introduction

7.1.4 Zoetis Revenue in Pet Pharmaceuticals Business (2020-2025)

7.1.5 Zoetis Recent Development

7.2 Boehringer Ingelheim

7.2.1 Boehringer Ingelheim Company Details

7.2.2 Boehringer Ingelheim Business Overview

7.2.3 Boehringer Ingelheim Pet Pharmaceuticals Introduction

7.2.4 Boehringer Ingelheim Revenue in Pet Pharmaceuticals Business (2020-2025)

7.2.5 Boehringer Ingelheim Recent Development

7.3 Merck

7.3.1 Merck Company Details

7.3.2 Merck Business Overview

7.3.3 Merck Pet Pharmaceuticals Introduction

7.3.4 Merck Revenue in Pet Pharmaceuticals Business (2020-2025)

7.3.5 Merck Recent Development

7.4 Elanco

7.4.1 Elanco Company Details

7.4.2 Elanco Business Overview

7.4.3 Elanco Pet Pharmaceuticals Introduction

7.4.4 Elanco Revenue in Pet Pharmaceuticals Business (2020-2025)

7.4.5 Elanco Recent Development

7.5 Virbac

7.5.1 Virbac Company Details

7.5.2 Virbac Business Overview

7.5.3 Virbac Pet Pharmaceuticals Introduction

7.5.4 Virbac Revenue in Pet Pharmaceuticals Business (2020-2025)

7.5.5 Virbac Recent Development

7.6 Dechra Veterinary Products

7.6.1 Dechra Veterinary Products Company Details

7.6.2 Dechra Veterinary Products Business Overview

7.6.3 Dechra Veterinary Products Pet Pharmaceuticals Introduction

7.6.4 Dechra Veterinary Products Revenue in Pet Pharmaceuticals Business (2020-2025)

7.6.5 Dechra Veterinary Products Recent Development

7.7 Ceva

7.7.1 Ceva Company Details

7.7.2 Ceva Business Overview

7.7.3 Ceva Pet Pharmaceuticals Introduction

7.7.4 Ceva Revenue in Pet Pharmaceuticals Business (2020-2025)

7.7.5 Ceva Recent Development

7.8 Vetoquinol

7.8.1 Vetoquinol Company Details

7.8.2 Vetoquinol Business Overview

7.8.3 Vetoquinol Pet Pharmaceuticals Introduction

7.8.4 Vetoquinol Revenue in Pet Pharmaceuticals Business (2020-2025)

7.8.5 Vetoquinol Recent Development

7.9 Ouro Fino Saude

7.9.1 Ouro Fino Saude Company Details

7.9.2 Ouro Fino Saude Business Overview

7.9.3 Ouro Fino Saude Pet Pharmaceuticals Introduction

7.9.4 Ouro Fino Saude Revenue in Pet Pharmaceuticals Business (2020-2025)

7.9.5 Ouro Fino Saude Recent Development

7.10 Norbrook

7.10.1 Norbrook Company Details

7.10.2 Norbrook Business Overview

7.10.3 Norbrook Pet Pharmaceuticals Introduction

7.10.4 Norbrook Revenue in Pet Pharmaceuticals Business (2020-2025)

7.10.5 Norbrook Recent Development

7.11 Jindun

7.11.1 Jindun Company Details

7.11.2 Jindun Business Overview

7.11.3 Jindun Pet Pharmaceuticals Introduction

7.11.4 Jindun Revenue in Pet Pharmaceuticals Business (2020-2025)

7.11.5 Jindun Recent Development

7.12 Chopperlvya Animal Health

7.12.1 Chopperlvya Animal Health Company Details

7.12.2 Chopperlvya Animal Health Business Overview

7.12.3 Chopperlvya Animal Health Pet Pharmaceuticals Introduction

7.12.4 Chopperlvya Animal Health Revenue in Pet Pharmaceuticals Business (2020-2025)

7.12.5 Chopperlvya Animal Health Recent Development

7.13 CAHIC

7.13.1 CAHIC Company Details

7.13.2 CAHIC Business Overview

7.13.3 CAHIC Pet Pharmaceuticals Introduction

7.13.4 CAHIC Revenue in Pet Pharmaceuticals Business (2020-2025)

7.13.5 CAHIC Recent Development

7.14 Animalcare Group

7.14.1 Animalcare Group Company Details

7.14.2 Animalcare Group Business Overview

7.14.3 Animalcare Group Pet Pharmaceuticals Introduction

7.14.4 Animalcare Group Revenue in Pet Pharmaceuticals Business (2020-2025)

7.14.5 Animalcare Group Recent Development

7.15 Parnell

7.15.1 Parnell Company Details

7.15.2 Parnell Business Overview

7.15.3 Parnell Pet Pharmaceuticals Introduction

7.15.4 Parnell Revenue in Pet Pharmaceuticals Business (2020-2025)

7.15.5 Parnell Recent Development

7.16 Ringpu

7.16.1 Ringpu Company Details

7.16.2 Ringpu Business Overview

7.16.3 Ringpu Pet Pharmaceuticals Introduction

7.16.4 Ringpu Revenue in Pet Pharmaceuticals Business (2020-2025)

7.16.5 Ringpu Recent Development

7.17 Jinyu Group

7.17.1 Jinyu Group Company Details

7.17.2 Jinyu Group Business Overview

7.17.3 Jinyu Group Pet Pharmaceuticals Introduction

7.17.4 Jinyu Group Revenue in Pet Pharmaceuticals Business (2020-2025)

7.17.5 Jinyu Group Recent Development

7.18 Kyoritsu Seiyaku

7.18.1 Kyoritsu Seiyaku Company Details

7.18.2 Kyoritsu Seiyaku Business Overview

7.18.3 Kyoritsu Seiyaku Pet Pharmaceuticals Introduction

7.18.4 Kyoritsu Seiyaku Revenue in Pet Pharmaceuticals Business (2020-2025)

7.18.5 Kyoritsu Seiyaku Recent Development

8 Pet Pharmaceuticals Market Dynamics

8.1 Pet Pharmaceuticals Industry Trends

8.2 Pet Pharmaceuticals Market Drivers

8.3 Pet Pharmaceuticals Market Challenges

8.4 Pet Pharmaceuticals Market Restraints

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Zoetis Inc

Boehringer Ingelheim

Elanco

Virbac

Dechra Veterinary Products

Ceva

Vetoquinol

Ouro Fino Saude

Norbrook

Jindun

Chopperlvya Animal Health

CAHIC

Merck

Animalcare Group

Parnell

ringpu

Jinyu Group

Kyoritsu Seiyaku

List of Tables

Table 1. Global Pet Pharmaceuticals Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Pet Pharmaceuticals Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Market Pet Pharmaceuticals Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Pet Pharmaceuticals Revenue (US$ Million) Market Share by Region (2020-2025)

Table 5. Global Pet Pharmaceuticals Revenue Share by Region (2020-2025)

Table 6. Global Pet Pharmaceuticals Revenue (US$ Million) Forecast by Region (2026-2031)

Table 7. Global Pet Pharmaceuticals Revenue Share Forecast by Region (2026-2031)

Table 8. Global Pet Pharmaceuticals Market Size by Type (2020-2025) & (US$ Million)

Table 9. Global Pet Pharmaceuticals Revenue Market Share by Type (2020-2025)

Table 10. Global Pet Pharmaceuticals Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 11. Global Pet Pharmaceuticals Revenue Market Share by Type (2026-2031)

Table 12. Representative Players of Each Type

Table 13. Global Pet Pharmaceuticals Market Size by Application (2020-2025) & (US$ Million)

Table 14. Global Pet Pharmaceuticals Revenue Market Share by Application (2020-2025)

Table 15. Global Pet Pharmaceuticals Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 16. Global Pet Pharmaceuticals Revenue Market Share by Application (2026-2031)

Table 17. New Sources of Growth in Pet Pharmaceuticals Application

Table 18. Global Pet Pharmaceuticals Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Pet Pharmaceuticals Market Share by Players (2020-2025)

Table 20. Global Top Pet Pharmaceuticals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Pharmaceuticals as of 2024)

Table 21. Ranking of Global Top Pet Pharmaceuticals Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Pet Pharmaceuticals Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Pet Pharmaceuticals, Headquarters and Area Served

Table 24. Global Key Players of Pet Pharmaceuticals, Product and Application

Table 25. Global Key Players of Pet Pharmaceuticals, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America Pet Pharmaceuticals Revenue by Company (2020-2025) & (US$ Million)

Table 28. North America Pet Pharmaceuticals Revenue Market Share by Company (2020-2025)

Table 29. North America Pet Pharmaceuticals Market Size by Type (2020-2025) & (US$ Million)

Table 30. North America Pet Pharmaceuticals Market Size by Application (2020-2025) & (US$ Million)

Table 31. Europe Pet Pharmaceuticals Revenue by Company (2020-2025) & (US$ Million)

Table 32. Europe Pet Pharmaceuticals Revenue Market Share by Company (2020-2025)

Table 33. Europe Pet Pharmaceuticals Market Size by Type (2020-2025) & (US$ Million)

Table 34. Europe Pet Pharmaceuticals Market Size by Application (2020-2025) & (US$ Million)

Table 35. China Pet Pharmaceuticals Revenue by Company (2020-2025) & (US$ Million)

Table 36. China Pet Pharmaceuticals Revenue Market Share by Company (2020-2025)

Table 37. China Pet Pharmaceuticals Market Size by Type (2020-2025) & (US$ Million)

Table 38. China Pet Pharmaceuticals Market Size by Application (2020-2025) & (US$ Million)

Table 39. Japan Pet Pharmaceuticals Revenue by Company (2020-2025) & (US$ Million)

Table 40. Japan Pet Pharmaceuticals Revenue Market Share by Company (2020-2025)

Table 41. Japan Pet Pharmaceuticals Market Size by Type (2020-2025) & (US$ Million)

Table 42. Japan Pet Pharmaceuticals Market Size by Application (2020-2025) & (US$ Million)

Table 43. Zoetis Company Details

Table 44. Zoetis Business Overview

Table 45. Zoetis Pet Pharmaceuticals Product

Table 46. Zoetis Revenue in Pet Pharmaceuticals Business (2020-2025) & (US$ Million)

Table 47. Zoetis Recent Development

Table 48. Boehringer Ingelheim Company Details

Table 49. Boehringer Ingelheim Business Overview

Table 50. Boehringer Ingelheim Pet Pharmaceuticals Product

Table 51. Boehringer Ingelheim Revenue in Pet Pharmaceuticals Business (2020-2025) & (US$ Million)

Table 52. Boehringer Ingelheim Recent Development

Table 53. Merck Company Details

Table 54. Merck Business Overview

Table 55. Merck Pet Pharmaceuticals Product

Table 56. Merck Revenue in Pet Pharmaceuticals Business (2020-2025) & (US$ Million)

Table 57. Merck Recent Development

Table 58. Elanco Company Details

Table 59. Elanco Business Overview

Table 60. Elanco Pet Pharmaceuticals Product

Table 61. Elanco Revenue in Pet Pharmaceuticals Business (2020-2025) & (US$ Million)

Table 62. Elanco Recent Development

Table 63. Virbac Company Details

Table 64. Virbac Business Overview

Table 65. Virbac Pet Pharmaceuticals Product

Table 66. Virbac Revenue in Pet Pharmaceuticals Business (2020-2025) & (US$ Million)

Table 67. Virbac Recent Development

Table 68. Dechra Veterinary Products Company Details

Table 69. Dechra Veterinary Products Business Overview

Table 70. Dechra Veterinary Products Pet Pharmaceuticals Product

Table 71. Dechra Veterinary Products Revenue in Pet Pharmaceuticals Business (2020-2025) & (US$ Million)

Table 72. Dechra Veterinary Products Recent Development

Table 73. Ceva Company Details

Table 74. Ceva Business Overview

Table 75. Ceva Pet Pharmaceuticals Product

Table 76. Ceva Revenue in Pet Pharmaceuticals Business (2020-2025) & (US$ Million)

Table 77. Ceva Recent Development

Table 78. Vetoquinol Company Details

Table 79. Vetoquinol Business Overview

Table 80. Vetoquinol Pet Pharmaceuticals Product

Table 81. Vetoquinol Revenue in Pet Pharmaceuticals Business (2020-2025) & (US$ Million)

Table 82. Vetoquinol Recent Development

Table 83. Ouro Fino Saude Company Details

Table 84. Ouro Fino Saude Business Overview

Table 85. Ouro Fino Saude Pet Pharmaceuticals Product

Table 86. Ouro Fino Saude Revenue in Pet Pharmaceuticals Business (2020-2025) & (US$ Million)

Table 87. Ouro Fino Saude Recent Development

Table 88. Norbrook Company Details

Table 89. Norbrook Business Overview

Table 90. Norbrook Pet Pharmaceuticals Product

Table 91. Norbrook Revenue in Pet Pharmaceuticals Business (2020-2025) & (US$ Million)

Table 92. Norbrook Recent Development

Table 93. Jindun Company Details

Table 94. Jindun Business Overview

Table 95. Jindun Pet Pharmaceuticals Product

Table 96. Jindun Revenue in Pet Pharmaceuticals Business (2020-2025) & (US$ Million)

Table 97. Jindun Recent Development

Table 98. Chopperlvya Animal Health Company Details

Table 99. Chopperlvya Animal Health Business Overview

Table 100. Chopperlvya Animal Health Pet Pharmaceuticals Product

Table 101. Chopperlvya Animal Health Revenue in Pet Pharmaceuticals Business (2020-2025) & (US$ Million)

Table 102. Chopperlvya Animal Health Recent Development

Table 103. CAHIC Company Details

Table 104. CAHIC Business Overview

Table 105. CAHIC Pet Pharmaceuticals Product

Table 106. CAHIC Revenue in Pet Pharmaceuticals Business (2020-2025) & (US$ Million)

Table 107. CAHIC Recent Development

Table 108. Animalcare Group Company Details

Table 109. Animalcare Group Business Overview

Table 110. Animalcare Group Pet Pharmaceuticals Product

Table 111. Animalcare Group Revenue in Pet Pharmaceuticals Business (2020-2025) & (US$ Million)

Table 112. Animalcare Group Recent Development

Table 113. Parnell Company Details

Table 114. Parnell Business Overview

Table 115. Parnell Pet Pharmaceuticals Product

Table 116. Parnell Revenue in Pet Pharmaceuticals Business (2020-2025) & (US$ Million)

Table 117. Parnell Recent Development

Table 118. Ringpu Company Details

Table 119. Ringpu Business Overview

Table 120. Ringpu Pet Pharmaceuticals Product

Table 121. Ringpu Revenue in Pet Pharmaceuticals Business (2020-2025) & (US$ Million)

Table 122. Ringpu Recent Development

Table 123. Jinyu Group Company Details

Table 124. Jinyu Group Business Overview

Table 125. Jinyu Group Pet Pharmaceuticals Product

Table 126. Jinyu Group Revenue in Pet Pharmaceuticals Business (2020-2025) & (US$ Million)

Table 127. Jinyu Group Recent Development

Table 128. Kyoritsu Seiyaku Company Details

Table 129. Kyoritsu Seiyaku Business Overview

Table 130. Kyoritsu Seiyaku Pet Pharmaceuticals Product

Table 131. Kyoritsu Seiyaku Revenue in Pet Pharmaceuticals Business (2020-2025) & (US$ Million)

Table 132. Kyoritsu Seiyaku Recent Development

Table 133. Pet Pharmaceuticals Market Trends

Table 134. Pet Pharmaceuticals Market Drivers

Table 135. Pet Pharmaceuticals Market Challenges

Table 136. Pet Pharmaceuticals Market Restraints

Table 137. Research Programs/Design for This Report

Table 138. Key Data Information from Secondary Sources

Table 139. Key Data Information from Primary Sources

List of Figures

Figure 1. Pet Pharmaceuticals Product Picture

Figure 2. Global Pet Pharmaceuticals Market Share by Type: 2024 VS 2031

Figure 3. Antiparasitic Features

Figure 4. Biological Products Features

Figure 5. Antibacterial Features

Figure 6. Others Features

Figure 7. Global Pet Pharmaceuticals Market Share by Application: 2024 VS 2031

Figure 8. Prevention

Figure 9. Treatment

Figure 10. Pet Pharmaceuticals Report Years Considered

Figure 11. Global Pet Pharmaceuticals Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global Pet Pharmaceuticals Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Pet Pharmaceuticals Revenue Market Share by Region: 2020 VS 2024

Figure 14. North America Pet Pharmaceuticals Revenue (US$ Million) Growth Rate (2020-2031)

Figure 15. Europe Pet Pharmaceuticals Revenue (US$ Million) Growth Rate (2020-2031)

Figure 16. China Pet Pharmaceuticals Revenue (US$ Million) Growth Rate (2020-2031)

Figure 17. Japan Pet Pharmaceuticals Revenue (US$ Million) Growth Rate (2020-2031)

Figure 18. Global Pet Pharmaceuticals Market Share by Players in 2024

Figure 19. Global Top Pet Pharmaceuticals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Pharmaceuticals as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Pet Pharmaceuticals Revenue in 2024

Figure 21. North America Pet Pharmaceuticals Market Share by Type (2020-2025)

Figure 22. North America Pet Pharmaceuticals Market Share by Application (2020-2025)

Figure 23. Europe Pet Pharmaceuticals Market Share by Type (2020-2025)

Figure 24. Europe Pet Pharmaceuticals Market Share by Application (2020-2025)

Figure 25. China Pet Pharmaceuticals Market Share by Type (2020-2025)

Figure 26. China Pet Pharmaceuticals Market Share by Application (2020-2025)

Figure 27. Japan Pet Pharmaceuticals Market Share by Type (2020-2025)

Figure 28. Japan Pet Pharmaceuticals Market Share by Application (2020-2025)

Figure 29. Zoetis Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)

Figure 30. Boehringer Ingelheim Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)

Figure 31. Merck Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)

Figure 32. Elanco Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)

Figure 33. Virbac Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)

Figure 34. Dechra Veterinary Products Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)

Figure 35. Ceva Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)

Figure 36. Vetoquinol Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)

Figure 37. Ouro Fino Saude Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)

Figure 38. Norbrook Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)

Figure 39. Jindun Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)

Figure 40. Chopperlvya Animal Health Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)

Figure 41. CAHIC Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)

Figure 42. Animalcare Group Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)

Figure 43. Parnell Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)

Figure 44. Ringpu Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)

Figure 45. Jinyu Group Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)

Figure 46. Kyoritsu Seiyaku Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)

Figure 47. Bottom-up and Top-down Approaches for This Report

Figure 48. Data Triangulation

Figure 49. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4250

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$6375

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$8500

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Preventive Medicine for Pets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antimicrobials for Pets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pet Insecticide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anti inflammatory Medicine for Pets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pet Intestinal Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Small Companion Animal Drug Market Research Report 2024

Global Pet Veterinary Drug Market Insights Forecast to 2030

Pet Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pet Antibiotic Market Research Report 2025

Pet Drug and Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Veterinary Drugs for Companion Animals Market Research Report 2025

Pet Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Companion Animal Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Animal Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pet Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pet Speciality Drugs Market

Global Pet Medicine Market Insights Forecast to 2030

OTC Pet Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pet Therapeutics Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions